These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21186397)

  • 21. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silanediol inhibitors of angiotensin-converting enzyme. Synthesis and evaluation of four diastereomers of Phe[Si]Ala dipeptide analogues.
    Kim J; Hewitt G; Carroll P; Sieburth SM
    J Org Chem; 2005 Jul; 70(15):5781-9. PubMed ID: 16018669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
    Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
    J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors.
    Kantevari S; Addla D; Bagul PK; Sridhar B; Banerjee SK
    Bioorg Med Chem; 2011 Aug; 19(16):4772-81. PubMed ID: 21782455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors.
    Sun Y; Bai Y; He X; Bai Y; Liu P; Zhao Z; Chen X; Zheng X
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29099799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of novel triazoles and mannich bases functionalized 1,4-dihydropyridine as angiotensin converting enzyme (ACE) inhibitors.
    Kumbhare RM; Kosurkar UB; Bagul PK; Kanwal A; Appalanaidu K; Dadmal TL; Banerjee SK
    Bioorg Med Chem; 2014 Nov; 22(21):5824-30. PubMed ID: 25300819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation, identification and molecular docking studies of a new isolated compound, from Onopordon acanthium: a novel angiotensin converting enzyme (ACE) inhibitor.
    Sharifi N; Souri E; Ziai SA; Amin G; Amini M; Amanlou M
    J Ethnopharmacol; 2013 Jul; 148(3):934-9. PubMed ID: 23743058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of ACE-inhibitory peptide associated with antioxidant and anticoagulation properties.
    Yu Z; Yin Y; Zhao W; Wang F; Yu Y; Liu B; Liu J; Chen F
    J Food Sci; 2011 Oct; 76(8):C1149-55. PubMed ID: 22417578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological activity of ketomethylene-containing nonapeptide analogues of snake venom angiotensin converting enzyme inhibitors.
    Almquist RG; Chao WR; Judd AK; Mitoma C; Rossi DJ; Panasevich RE; Matthews RJ
    J Med Chem; 1988 Mar; 31(3):561-7. PubMed ID: 2831364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril.
    Akif M; Masuyer G; Schwager SL; Bhuyan BJ; Mugesh G; Isaac RE; Sturrock ED; Acharya KR
    FEBS J; 2011 Oct; 278(19):3644-50. PubMed ID: 21810173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors.
    Addla D; Jallapally A; Kanwal A; Sridhar B; Banerjee SK; Kantevari S
    Bioorg Med Chem; 2013 Aug; 21(15):4485-93. PubMed ID: 23777825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Understanding of the Relationship between Bioactive Compounds of Black Tea and its Angiotensin Converting Enzyme (ACE) Inhibition and Antioxidant Activity.
    Wang L; Ma L; Zhao Y; Shu G; Li J; Chen L
    Plant Foods Hum Nutr; 2021 Jun; 76(2):226-232. PubMed ID: 33988839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.
    Manikandan A; Moharil P; Sathishkumar M; Muñoz-Garay C; Sivakumar A
    Eur J Med Chem; 2017 Dec; 141():417-426. PubMed ID: 29032034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin I-converting enzyme inhibitor activity of nutritive plants in KwaZulu-Natal.
    Ramesar S; Baijnath H; Govender T; Mackraj I
    J Med Food; 2008 Jun; 11(2):331-6. PubMed ID: 18598177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis of novel Triazolones and bis-Triazolones derivatives under ultrasound irradiation and evaluation as potent angiotensin converting enzyme (ACE) inhibitors.
    Ben Salah B; Hamzaoui S; Krichen F; Saadaoui I; Ben Mansour R; Miled N; Bougatef A; Kossentini M
    Bioorg Chem; 2018 Feb; 76():147-153. PubMed ID: 29175586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
    Yoo YJ; Nam DH; Jung SY; Jang JW; Kim HJ; Jin C; Pae AN; Lee YS
    Bioorg Med Chem Lett; 2011 May; 21(10):2850-4. PubMed ID: 21504847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ACE pharmacophore in the phosphonopeptide metabolite K-26.
    Ntai I; Bachmann BO
    Bioorg Med Chem Lett; 2008 May; 18(10):3068-71. PubMed ID: 18096385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors.
    Turbanti L; Cerbai G; Di Bugno C; Giorgi R; Garzelli G; Criscuoli M; Renzetti AR; Subissi A; Bramanti G; DePriest SA
    J Med Chem; 1993 Mar; 36(6):699-707. PubMed ID: 8459398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient synthesis of a chiral precursor for angiotensin-converting enzyme (ACE) inhibitors in high space-time yield by a new reductase without external cofactors.
    Shen ND; Ni Y; Ma HM; Wang LJ; Li CX; Zheng GW; Zhang J; Xu JH
    Org Lett; 2012 Apr; 14(8):1982-5. PubMed ID: 22480179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.